Effects of progestins on progesterone synthesis in a stable porcine granulosa cell line: control of transcriptional activity of the cytochrome p450 side-chain cleavage gene.
The purpose of the present study was to examine the effects of progestins on progesterone synthesis and expression of the cytochrome P450 cholesterol side-chain cleavage gene (P450(scc)) in a stable porcine granulosa cell line, the JC-410. Cells were incubated for 48 h with the synthetic progestogen-levornorgestrel with or without RU486 (progesterone and glucocorticoid receptor antagonist) or RWJ26819 (progesterone agonist without affinity to glucocorticoid receptors). Both levonorgestrel and RU486 enhanced progesterone accumulation in a dose-dependent manner. RU486 did not antagonize the effects of levonorgestrel, and RWJ26819 had no effect on progesterone production in cultured JC-410 cells. Progesterone and levonorgestrel increased steady state P450(scc) mRNA levels after 3-6 h of treatment. Progesterone and RU486 at 0.1, 1, and 10 microM increased the transcription rate of P450(scc) transiently expressed in JC-410 cells after 18 h of incubation; 30 microM had no effect, and 100 microM suppressed transcription. Levonorgestrel did not affect transcription of the P450(scc) gene, and RWJ26819 reduced its transcription. Progesterone and RU486 significantly decreased the number of cells and total protein content after 72 and 24 h of incubation, respectively. Levonorgestrel had no effect, whereas RWJ26819 increased (24 h) but subsequently reduced (72 h) cell number and protein content. The present results indicate that progestins are capable of directly modulating progesterone biosynthesis in porcine JC-410 granulosa cells. These effects may be exerted in part through the regulation of P450(scc) gene expression. Ostensible differences exist between progesterone and its synthetic analogues in the control of progesterone secretion in the stable porcine granulosa cell line in vitro.
Swan
C L
CL
Department of Obstetrics, Gynecology & Reproductive Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N OW8.
Agostini
M C
MC
Bartlewski
P M
PM
Feyles
V
V
Urban
R J
RJ
Chedrese
P J
PJ
D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000235:genetics*; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D006107:Granulosa Cells / Q000187:drug effects* / Q000378:metabolism*; D007700:Kinetics; D016912:Levonorgestrel / Q000494:pharmacology; D015735:Mifepristone / Q000494:pharmacology; D011374:Progesterone / Q000096:biosynthesis* / Q000494:pharmacology; D011372:Progestins / Q000494:pharmacology*; D011724:Pyridazines / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis; D013552:Swine / Q000378:metabolism*; D014158:Transcription, Genetic / Q000187:drug effects
D011372:Progestins; D011724:Pyridazines; D012333:RNA, Messenger; C423502:RWJ 26819; D015735:Mifepristone; D011374:Progesterone; D016912:Levonorgestrel; D002786:Cholesterol Side-Chain Cleavage Enzyme